MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):371-376. doi: 10.15585/mmwr.mm6913a3.
In 2017, drug overdoses caused 70,237 deaths in the United States, a 9.6% rate increase from 2016 (1). Monitoring nonfatal drug overdoses treated in emergency departments (EDs) is also important to inform community prevention and response activities. Analysis of discharge data provides insights into the prevalence and trends of nonfatal drug overdoses, highlighting opportunities for public health action to prevent overdoses. Using discharge data from the Healthcare Cost and Utilization Project's (HCUP) Nationwide Emergency Department Sample (NEDS), CDC identified nonfatal overdoses for all drugs, all opioids, nonheroin opioids, heroin, benzodiazepines, and cocaine and examined changes from 2016 to 2017, stratified by drug type and by patient, facility, and visit characteristics. In 2017, the most recent year for which population-level estimates of nonfatal overdoses can be generated, a total of 967,615 nonfatal drug overdoses were treated in EDs, an increase of 4.3% from 2016, which included 305,623 opioid-involved overdoses, a 3.1% increase from 2016. From 2016 to 2017, the nonfatal overdose rates for all drug types increased significantly except for those involving benzodiazepines. These findings highlight the importance of continued surveillance of nonfatal drug overdoses treated in EDs to inform public health actions and, working collaboratively with clinical and public safety partners, to link patients to needed recovery and treatment resources (e.g., medication-assisted treatment).
2017 年,美国因药物过量导致 70237 人死亡,与 2016 年相比增长了 9.6%(1)。监测在急诊部(ED)治疗的非致命性药物过量情况,对于开展社区预防和应对活动也很重要。对出院数据进行分析可以深入了解非致命性药物过量的流行率和趋势,为采取公共卫生行动预防过量提供机会。美国疾病控制与预防中心(CDC)利用医疗保健成本和利用项目(HCUP)全国急诊部抽样(NEDS)的出院数据,确定了所有药物、所有阿片类药物、非海洛因类阿片类药物、海洛因、苯二氮䓬类药物和可卡因的非致命性药物过量情况,并按药物类型和患者、医疗机构和就诊特征进行分层,分析了 2016 年至 2017 年的变化情况。在 2017 年,即可以生成非致命性药物过量人群水平估计值的最新一年,共有 967615 例非致命性药物过量在 ED 中得到治疗,比 2016 年增加了 4.3%,其中涉及 305623 例阿片类药物过量,比 2016 年增加了 3.1%。2016 年至 2017 年,除涉及苯二氮䓬类药物的非致命性药物过量率外,所有药物类型的非致命性药物过量率均显著增加。这些发现突出表明,需要继续对在 ED 中治疗的非致命性药物过量情况进行监测,以为公共卫生行动提供信息,并与临床和公共安全合作伙伴合作,将患者与所需的康复和治疗资源(例如,药物辅助治疗)联系起来。